Total serum IgE variations in infants with bronchitis or asthma

P. P. Ramos, L. L. Arrieta, E. E. Perez-Yarza, R. R. Gotarredona, A. A. Iturrioz, J. J. Casafont (Vitoria, San Sebastian, Spain)

Source: Annual Congress 2002 - The development of allergic sensitization / asthma in children
Session: The development of allergic sensitization / asthma in children
Session type: Thematic Poster Session
Number: 779
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Abstract

In Spain 30% of the visits to the paediatrician are related to respiratory processes, specially asthma and bronchitis. Both illnesses have increased substantially in the last years. Many studies show a relationship between the previous onset of bronchitis and the following situations of pediatric asthma.
In our study we have quantified total serum IgE variations (ELISA or Immunonephelometry) in 653 infants from 3 to 36 months old investigating different situations: healthy (H, n=185), recurrent bronchitis (RB, n=138), wheezing bronchitis (WB, n=115) and allergic asthmatic patients (AA, n=215).
The higher IgE mean values have corresponded to the AA group (71±] 11¿02 UI/ml) followed by WB (34¿1±] 61¿6), BR (9¿15±] 12¿3) and H (6¿7±] 6¿12 UI/ml). There are significant differences (p <0¢ 05) between H and AA and WB but not between H and BR. Something similar happens with the IgE percentage levels < 15 UI/ml for each group: H, 83%; BR 67%; WB, 62% and AA, 28% (p< 0¿05 of H with the rest of the groups).

GroupnAge (months)IgE total (UI/ml)%<15 UI/mlp
H18515'36'7±]6'1283%-
RB13811'69'15±]12'367%0'19
WB11511'134'1±]61'662%0'04
AA21516'771±]110'228%0'02


These results suggest some allergic factor in WB and could help us to understand the following evolution from WB to allergic asthma and, finally, they support the use of anti-IgE drugs in the treatment of some infant allergic asthma.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. P. Ramos, L. L. Arrieta, E. E. Perez-Yarza, R. R. Gotarredona, A. A. Iturrioz, J. J. Casafont (Vitoria, San Sebastian, Spain). Total serum IgE variations in infants with bronchitis or asthma. Eur Respir J 2002; 20: Suppl. 38, 779

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Allergic asthma: total serum IgE age variations
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

Elevated serum ECP in wheezing infants predicts the development of atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 192s
Year: 2002

β2-adrenergic polymorphisms and serum total IgE levels in children with asthma
Source: Annual Congress 2007 - Risk factors for childhood asthma: genetic and population studies
Year: 2007


Specific serum IgE is associated with seasonal symptom load in children with allergic rhinitis
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008


Epidemiology of serum IgE in children with allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 373s
Year: 2001

Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Effect of urbanisation on the relationship between total serum IgE and asthma
Source: Eur Respir J 2013; 41: 1074-1081
Year: 2013



Serum total IgE level is associated with new-onset asthma and lung function decline in atopics but not in non atopics: A longitudinal study
Source: Annual Congress 2010 - Highlights of longitudinal, geographical and time trend studies of asthma and COPD
Year: 2010


Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Monitoring free serum IgE in severe asthma patients treated with omalizumab
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002

Plasma eotaxin level in children with acute bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003

Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Monitoring free serum IgE in asthma patients treated with omalizumab
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010

Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Serum levels of interleukin-1α in patients affected by atopic and non atopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

Serum myeloperoxidase in wheezing infants: is there an association with later asthma?
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009


Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005

Association of serum IgE level and phadiatop with asthma, rhinitis and smoking in an elderly population from PAQUID cohort
Source: Eur Respir J 2001; 18: Suppl. 33, 436s
Year: 2001